Sirt1 is a histone deacetylase (HDAC) and plays an important role in epigenomic profiling in MM by modulating the expression of P53 and miRNA-34a, and its targeting is suggested as a treatment strategy for MM [31]. Here, HDAC9 is linked to Miyoshi myopathy.